FDA Classifies Inventia Healthcare Chlorthalidone Recall as Class II
核心洞察
Inventia Healthcare recalled an additional lot of chlorthalidone 25 mg tablets on September 3, and the FDA classified that action as Class II on September 17.
The recall covers more than 13,000 bottles of chlorthalidone tablets, USP, 25 mg, 100 tablets per bottle, batch RISA24002, expiring 04/2027.
The stated reason is failed dissolution specifications, which may reduce absorption of the active ingredient and make the diuretic less effective at lowering blood pressure.
Inventia Healthcare has recalled an additional lot of chlorthalidone tablets, a diuretic used to treat high blood pressure (搜索), and the FDA classified the September action as Class II on September 17. The company initiated the separate recall on September 3. An earlier recall of certain lots of the same medication, launched in June, has also been classified as Class II.
Scope of the September Recall
The September recall involves more than 13,000 bottles. The affected product is chlorthalidone tablets, USP, 25 mg, 100 tablets per bottle, Rx only, manufactured by Inventia Healthcare Limited. The National Drug Code is 64980-599-01, the batch number is RISA24002, and the expiration date is 04/2027. Patients who cannot confirm all of this information on their prescription label should contact their pharmacist for help.
What Class II Means
Under the FDA's classification system, a Class II recall indicates that use of or exposure to the recalled product may cause temporary or medically reversible health issues, but the probability of those issues being serious is considered remote.
Dissolution Failure and Therapeutic Implications
The reason for the recall is listed as failed dissolution specifications. The FDA defines proper dissolution as the active ingredient dissolving from its dosage form so it can be absorbed by the body. When a medication does not dissolve as intended, the body may not absorb enough of the active ingredient, which could make the drug less effective at treating the condition it was prescribed for. Neither Inventia Healthcare nor the FDA has provided further information about the reason for this specific recall.
Clinical Role of Chlorthalidone
Chlorthalidone is a diuretic, often called a water pill, that prompts the kidneys to shed excess water and salt. This lowers high blood pressure (搜索) and reduces water retention, which in turn lessens the chances of organ damage that could lead to heart attack, heart disease, heart failure (搜索), stroke (搜索), kidney damage, or eye damage that could affect vision.
Guidance for Patients
Patients holding the recalled medication should contact their healthcare provider right away. Decisions about stopping the medication should not be made without medical guidance. Any feeling of illness should be reported to a doctor immediately.